Wenjing Zhao

Wenjing Zhao, Ph.D. has a diverse work experience spanning various roles and industries.

Wenjing is currently working as the Director of US New Products at Shionogi Inc., starting in December 2022.

Prior to that, they worked at Mitsubishi Tanabe Pharma America from January 2020 to December 2022 as an Associate Director in Corporate & Product Strategy. In this role, they worked closely with senior management and global headquarters in Japan, focusing on neurology, immuno-inflammation, and rare diseases. Wenjing received a Performance Recognition Award in 2022 for their outstanding achievements.

From October 2016 to December 2019, Wenjing worked at Amgen as a Senior Manager in Commercial Strategy & Analytics. Wenjing was responsible for delivering market insights, demand forecasts, and strategic recommendations for product launches and growth development. Wenjing was awarded the Most Valuable Partner and Acclaim 3 Star for their exceptional contributions during their tenure.

Before that, Wenjing served as a Management Consultant at Michael Allen Company from 2013 to 2016, and as a Clinical Research Analyst at Columbia University Medical Center from 2011 to 2013.

Wenjing also gained experience as a Worldwide Market Access Intern at Janssen, Pharmaceutical Companies of Johnson and Johnson in June to August 2012.

With their strong background in strategy, analytics, and research, Wenjing Zhao, Ph.D. brings a wealth of expertise to their current role as Director of US New Products at Shionogi Inc.

Wenjing Zhao, Ph.D. completed a Master of Science (M.S.) degree in Public Health, with a specialization in Biostatistics, from Columbia University. Subsequently, they pursued a Ph.D. in Biochemistry & Bioengineering from Rensselaer Polytechnic Institute. Wenjing Zhao completed their undergraduate studies at Fudan University, earning a Bachelor of Science (B.S.) degree in Biological Sciences. Additionally, they obtained certification in an Advanced Business Development Course from EBD Group in November 2021.